Identify novel cancer therapeutic solutions with our 3D InSight™ Oncology Drug Discovery Platform
InSphero's 3D InSight™ Oncology Drug Discovery Services for efficacy drug testing and immuno-oncology applications are designed to accelerate oncology drug discovery and help you gain greater translational insights.
Outsource your 3D tumor model development and preclinical testing of anti-cancer drugs to InSphero. We work with you to develop and implement a detailed study plan and ensure you get robust and reliable results, comprehensive reporting, and analysis of your oncology data.
- Design a better model composed of the appropriate ratio of tumor cells, derived from a cancer cell line or PDX material, and stromal cell components
- Test potency and efficacy of cancer drugs in a physiologically relevant 3D model that better reflects the complex biology of tumor
- Assess single agent or combinatorial efficacy of small molecule, biological, ADC, or immunomodulatory drugs using 3D optimized endpoints
- Evaluate infiltration of immune cells or the effect of your drug on immune-cell infiltration
Custom Tumor Model Development for Oncology Drug Discovery
Build a model with tumor and stromal components derived from cell line, PDX, or primary patient material.
Combinatorial Drug Testing
Test for synergistic effects of drug combinations in 3D InSight™ Tumor Microtissues.
Optimize biological construct design by assessing antibody penetration into tumor microtissues.
Evaluate immune cell infiltration, tumor cell killing, and immuno-therapeutic efficacy